Citing uncertainties related to the COVID-19 pandemic, CryoLife (NYSE:CRY) has withdrawn its 2020 guidance, although it expects Q1’s top line to be ~$65.5M, a bit shy of its previous outlook of $67M – 69M.
As a precautionary measure, it borrowed the entire
available amount under its $30M credit revolver. As of the end of
March, it had over $60M in cash and equivalents.
https://seekingalpha.com/news/3557547-cryolife-withdraws-guidance-amid-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.